Drug Type Chemical drugs |
Synonyms HJ787 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodermatitis | Phase 1 | CN | 13 Nov 2023 | |
Dermatitis, Atopic | IND Approval | CN | 26 Apr 2024 | |
Psoriasis | IND Approval | CN | 26 Apr 2024 | |
inflammatory dermatosis | IND Approval | CN | 26 Sep 2023 |